IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fate Therapeutics
AstraZeneca
Neonc Technologies, Inc.
Nurix Therapeutics, Inc.
Merck Sharp & Dohme LLC
Sun Yat-sen University
AIDS Malignancy Consortium
Oncology Institute of Southern Switzerland
Roswell Park Cancer Institute